InvestorsHub Logo
Followers 163
Posts 19580
Boards Moderated 2
Alias Born 12/09/2004

Re: nidan7500 post# 210921

Saturday, 09/21/2019 5:18:10 PM

Saturday, September 21, 2019 5:18:10 PM

Post# of 458359

Isn't this the strong base for Precision Medicine? The search for and application of those relevant facts/hard data that can be measured and correlated.



Sort of. As I understand it, precision medicine allows Drs to determine in advance if a drug or treatment will work for an individual patient. Implicit in that is that the drug or treatment doesn't work for everyone so the precision part allows the use of a test or biomarker to determine which patients will benefit. That saves time and money.

The other side of that is if the drug or treatment works for all patients then there is no need for the precision medicine.

For 2-73 and AD, the current information is that 2-73 will have a positive effect for all of the genotypes. It will have a stronger effect on those patients with the wild type genes. If that is the case 2-73 will be prescribed for all AD patients. Maybe those with the mutated gene form will get a stronger dose?

Right now the distinction is only being used to allow for statistical analysis of the two groups. If the response difference holds up to statistical analysis then the company will have to decide what to do with that information.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News